Novavax
Late-stage biotechnology company focused on the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. Learn more
Launch date
Employees
Market cap
AUD3.0b
Enterprise valuation
AUD1.7b (Public information from Sep 2024)
Share price
$12.56 NVAX
Gaithersburg Maryland (HQ)
Authorizing premium user...